Heron Therapeutics Inc

NASDAQ:HRTX   3:59:59 PM EDT
17.34
-0.65 (-3.61%)
Products

Heron Therapeutics Resubmits New Drug Application To FDA For Htx-011 For The Treatment Of Postoperative Pain

Published: 11/13/2020 13:39 GMT
Heron Therapeutics Inc (HRTX) - Heron Therapeutics Resubmits New Drug Application to FDA for Htx-011 for the Treatment of Postoperative Pain.
Heron Therapeutics - in Resubmission, Provided Evidence Responding to Issues Identified in Crl That Should Provide Basis for Approval of Htx-011 NDA.